Sumitomo Pharma Oncology
is part of Sumitomo Pharma America as of July 2023
49 employees · est. 2020 · Cambridge, United States
Sunesis Pharmaceuticals, Inc. is the older company (2020 vs 1987).
Side-by-Side Comparison
| Metric | Sumitomo Pharma Oncology | Sunesis Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 1987 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | South San Francisco, United States |
| Employees | ||
| Employees | 49 | 42 |
| Industry | ||
| Industry | Health Care, Health and Wellness, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $221.70M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 9 |
| Services | ||
| Services | Drug Discovery, Development and Commercialization, Clinical Research, Innovative Treatment Solutions, Science and Technology Advancements | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients, Healthcare Providers, Caregivers, Medical Institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Cancer Therapeutics, Oncology Research, Clinical Development, Oncogenic Pathways, Survival Mechanisms, Novel Protein Interactions, Drug Discovery, Drug Development, External Innovation, Patient-Centric Innovation, Therapeutic Breakthroughs, Research And Development, Cancer Treatment Resistance, Tumor Progression | Biopharmaceutical Company, Oncology Therapeutics, Cancer Drug Development, Kinase-inhibitor Pipeline, Vecabrutinib, Chronic Lymphocytic Leukemia, Translational Science, Clinical Research, Tumor Growth Inhibition, Innovation-driven, Pharmaceutical Industry, Cancer Treatment, Philanthropy, Healthcare Advancements |
| Website | ||
| Website | oncology.sumitomo-pharma.com | sunesis.com |
About Sumitomo Pharma Oncology
Sumitomo Pharma Oncology is a subsidiary of the global pharmaceutical company Sumitomo Pharma Co., Ltd., now operating as part of Sumitomo Pharma America (SMPA) as of July 2023. Although the company's standalone pages are inactive, its mission under SMPA reflects a commitment to pioneering drug deve...
About Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1998 with a focus on developing and commercializing new oncology therapeutics for hematologic and solid tumor cancers. The company's commitment to advancing oncology treatment and patient care is evident in its emphasis on its n...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Sumitomo Pharma Oncology and Sunesis Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Sumitomo Pharma Oncology or Sunesis Pharmaceuticals, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Sumitomo Pharma Oncology with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Sumitomo Pharma Oncology on 7 Apr 2026, and Sunesis Pharmaceuticals, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
